Press Releases YS Biopharma Co., Ltd.

Equities

YS

KYG9845F1090

Delayed Nasdaq Other stock markets 12:31:09 25/05/2024 am IST			5-day change	1st Jan Change
0.9544 ^USD	+5.21%		-2.98%	+85.68%

04:36pm	YS Biopharma to Become LakeShore Biopharma, Ticker Symbol to Change to LSB From YS Starting May 28	MT
21/05	YS Biopharma Co., Ltd. Approves Board Appointments	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

YS Biopharma Announces Name Change to LakeShore Biopharma	05:01pm	PR
YS Biopharma Announces Results of Extraordinary General Meeting	22/05	PR
YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer	08/05	PR
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule	29/04	PR
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024	22/04	AQ
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024	19/04	PR
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine	18/04	PR
YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024	16/04	PR
YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine	09/04	PR
YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility	03/04	PR
YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries	05/03	PR
YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024	23/02	PR
/C O R R E C T I O N -- YS Biopharma Co., Ltd./	17/02	PR
YS Biopharma Announces Appointment of New Directors	15/02	AQ
YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate Governance	14/02	PR
YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd.	12/02	PR
YS Biopharma Announces US$40 Million Private Placement Financing	09/02	PR
YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024	23/01	PR
YS Biopharma Announces Changes to its Board Committees	08/01	PR
YS Biopharma : ANY OTHER PERSON WHO KNOWS OF THIS ORDER AND DOES ANYTHING WHICH HELPS OR PERMITS YI ZHANG TO BREACH THE TERMS OF THIS ORDER MAY ALSO BE HELD TO BE IN CONTEMPT OF COURT AND MAY BE IMPRISONED, FINED OR HAVE THEIR ASSETS SEIZED - Form 6-K	29/12	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases YS Biopharma Co., Ltd.

Equities

YS

KYG9845F1090

Press Releases

Filters